Literature DB >> 727793

Pyridoxol metabolism in vitamin B6-responsive convulsions of early infancy.

A Heeley, R J Pugh, B E Clayton, J Shepherd, J Wilson.   

Abstract

As there is uncertainty about the nature of the metabolic defect in vitamin B6-responsive convulsion, certain aspects of pyridoxol metabolism were studied in 3 patients who were believed on clinical grounds to have the condition. The findings were compared with those in healthy children and adults, and in children with mental handicap. The magnitude of the initial rise and the subsequent fall in plasma pyridoxal phosphate (PALP) concentrations after a load of pyridoxol suggested that the vitamin B6-responsive patients were able to synthesise PALP normally but were unable to maintain the prolonged high levels normally found in plasma. The urinary excretion of 4-pyridoxic acid was within normal limits, but the excretion of pyridoxol after the load was raised. It is suggested that there may be an instability of the PALP-albumin complex in this condition. Some of the biochemical features were also observed in an infant presenting with convulsions soon after birth but without evidence of clinical B6-dependency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727793      PMCID: PMC1545388          DOI: 10.1136/adc.53.10.794

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  URINARY VITAMIN B6 AND 4-PYRIDOXIC ACID IN HEALTH AND IN VITAMIN B6 DEPENDENCY.

Authors:  C R SCRIVER; A M CULLEN
Journal:  Pediatrics       Date:  1965-07       Impact factor: 7.124

2.  The specific binding of pyridoxal 5'-phosphate to bovine plasma albumin.

Authors:  W B DEMPSEY; H N CHRISTENSEN
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  The enzymatic oxidation of pyridoxine and pyridoxamine phosphates.

Authors:  H WADA; E E SNELL
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

4.  The reaction of pyridoxal 5-phosphate with cyanide and its analytical use.

Authors:  V BONAVITA
Journal:  Arch Biochem Biophys       Date:  1960-06       Impact factor: 4.013

5.  The determination of 4-pyridoxic acid in human urine.

Authors:  S K REDDY; M S REYNOLDS; J M PRICE
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

6.  Nature of the binding site of pyridoxal 5'-phosphate to bovine serum albumin.

Authors:  J A Anderson; H W Chang; C J Grandjean
Journal:  Biochemistry       Date:  1971-06-08       Impact factor: 3.162

7.  The effect of pyridoxal phosphate on the aminotransferase assay in blood.

Authors:  A Hamfelt
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

8.  Studies on the metabolism of labeled pyridoxine in man.

Authors:  S Johansson; S Lindstedt; U Register; L Wadström
Journal:  Am J Clin Nutr       Date:  1966-03       Impact factor: 7.045

9.  Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine.

Authors:  A D HUNT; J STOKES; W W McCRORY; H H STROUD
Journal:  Pediatrics       Date:  1954-02       Impact factor: 7.124

Review 10.  VITAMIN B6 METABOLISM IN INFANTS AND CHILDREN.

Authors:  D B COURSIN
Journal:  Vitam Horm       Date:  1964       Impact factor: 3.421

View more
  6 in total

1.  The early detection and management of inborn errors presenting acutely in the neonatal period.

Authors:  J V Leonard
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

2.  Megavitamin therapy in inherited metabolic disorders.

Authors:  S C Kalhan
Journal:  Indian J Pediatr       Date:  1981 Sep-Oct       Impact factor: 1.967

3.  Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.

Authors:  R Nabbout; C Soufflet; P Plouin; O Dulac
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

4.  Pyridoxine dependent seizures--a wider clinical spectrum.

Authors:  A Bankier; M Turner; I J Hopkins
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

Review 5.  Pyridoxine-dependent seizures, clinical and therapeutic aspects.

Authors:  C A Haenggeli; E Girardin; L Paunier
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

Review 6.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.